Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations

Early onset of type 2 diabetes and a high prevalence of co‐morbidities predispose the Asian population to a high risk for, and rapid progression of, diabetic kidney disease (DKD). Apart from renin‐angiotensin system inhibitors, sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors have been shown to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoo, Chin Meng, Deerochanawong, Chaicharn, Chan, Siew Pheng, Matawaran, Bien, Sheu, Wayne Huey‐Herng, Chan, Juliana, Mithal, Ambrish, Luk, Andrea, Suastika, Ketut, Yoon, Kun‐Ho, Ji, Linong, Man, Nguyen Huu, Pollock, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839543/
https://www.ncbi.nlm.nih.gov/pubmed/33155749
http://dx.doi.org/10.1111/dom.14251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839543/
https://www.ncbi.nlm.nih.gov/pubmed/33155749
http://dx.doi.org/10.1111/dom.14251

Ejemplares similares